Roche’s OCREVUS approved for relapsing and primary progressive multiple sclerosis in Australia Read more
ShangPharma Innovation and the University of California San Francisco Announce Strategic Research Collaboration Read more
FDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria Read more